HFNC During Bronchoscopy in COPD Patients

ConditionCOPD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe First Affiliated Hospital of Guangzhou Medical University

About this trial

Bronchoscopy diagnosis and treatment is highly irritating, and the effect of local topical anesthesia is poor; the airway is shared; and COPD patients have low oxygen reserves due to impaired lung function. At present, clinical anesthesia generally uses nasal cannula for oxygen inhalation. If the anesthesia is too shallow, it may cause airway spasm, and if the anesthesia is too deep, it will inhibit breathing and lead to hypoxia. Hypoxemia has been reported in 66% of COPD patients undergoing sedation for bronchoscopy. Therefore, solving hypoxia is the biggest problem in anesthesia for bronchoscopy diagnosis and treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

COPD ,(ASA)Ⅰ ~ Ⅲ

Disqualifiers

Contraindications to bronchoscopy or anesthesia, Nosebleeds

Trial design

Design model

Parallel

Treatments tested in this trial

  • group N used traditional nasal cannula for oxygen inhalation

    Other intervention

    1000 COPD patients who underwent bronchoscopy were randomly divided into 2 groups in a 1:1 ratio.Nasal high-flow oxygen therapy group(group N) and nasal cannula oxygen inhalation group(group HFNC).The N group used traditional nasal cannula for oxygen inhalation, and the HFNC group used nasal high-flow oxygen inhalation.

  • Group HFNC used nasal high-flow oxygen inhalation.

    Other intervention

    1000 COPD patients who underwent bronchoscopy were randomly divided into 2 groups in a 1:1 ratio.Nasal high-flow oxygen therapy group(group N) and nasal cannula oxygen inhalation group(group HFNC).The N group used traditional nasal cannula for oxygen inhalation, and the HFNC group used nasal high-flow oxygen inhalation.

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: Group NOther 1 intervention
Group B: Group HFNCExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

pulse oximetry

Blood oxygen saturation during anesthesia, record the duration and number of times below 90%

Time frame
The entire anesthesia period during bronchoscopy

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: